ITEMS IN AFP WITH KEYWORD:
The American Academy of Sleep Medicine (AASM) last published recommendations on the treatment of restless legs syndrome (RLS) and periodic limb movement disorder in 2004. It recently updated these recommendations based on a literature review and meta-analysis.
What are the effects of nondrug and drug treatments for primary insomnia in older persons (those 60 years and older)?
The updated guidelines on central sleep apnea from the American Academy of Sleep Medicine (AASM) includes levels of recommendations (standard or option) based on the overall quality of evidence (high, moderate, low, or very low). Central sleep apnea syndromes are characterized by sleep-disordered br...
Feb 1, 2012 Issue
Respiratory Indications for Polysomnography in Children [Practice Guidelines]
Although assessment of sleep disorders in children relies on the history and physical examination, polysomnography (PSG) is sometimes used to aid in the diagnosis. The American Academy of Sleep Medicine has provided recommendations regarding the use of the test in children. This guideline focuses on...
Nov 1, 2011 Issue
Antidepressants for the Treatment of Insomnia in Patients with Depression [FPIN's Clinical Inquiries]
There is no single antidepressant or class of antidepressants that is most effective for the treatment of insomnia in patients with depression. The use of antidepressant medications can have a positive impact on sleep physiology, but does not seem to improve subjective ratings of sleep quality.
In older patients with primary insomnia, Silenor can increase duration of sleep without next-day effects. However, it does not significantly decrease the time to sleep onset, and it is less effective in younger adults.
Clinical indicators (e.g., sex, snoring severity, history of apnea, age, menopausal status, waist-to-hip ratio, body habitus) can predict OSA as diagnosed using overnight polysomnography or sleep study.
What are the effects of treatment for severe and nonsevere OSAHS?
Excessive daytime sleepiness is one of the most common sleep-related patient symptoms, and it affects an estimated 20 percent of the population. Persons with excessive daytime sleepiness are at risk of motor vehicle and work-related incidents, and have poorer health than comparable adults. The most ...
Chronic insomnia is highly prevalent in our society, with an incidence of 10 to 30 percent. It is a major cost to society in terms of health care expenditure and reduced productivity. Nonpharmacologic interventions have been studied and shown to produce reliable and sustained improvements in sleep p...